CD133+CD44+ cancer cells have been characterized in several highly metastatic tumors, such as CRCs [46-48], HCCs [49,50], pancreatic cancer [51], gallbladder carcinoma [52], lung adenocarcinomas [53] and gastric cancer [54]. The gene discussed is PROM1; the disease is cancer.